Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? — CFSMEATLAS
Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Castro-Marrero, Jesús, Domingo, Joan Carles, Cordobilla, Begoña et al. · Antioxidants & redox signaling · 2022 · DOI
Quick Summary
This study tested whether taking Coenzyme Q10 and selenium supplements together could help ME/CFS patients feel better. Twenty-seven patients took these supplements daily for 8 weeks, and researchers measured their fatigue, quality of life, sleep, and blood markers related to stress and inflammation. The supplements improved overall fatigue and quality of life, and blood tests showed reduced oxidative stress and inflammation, though sleep did not improve.
Why It Matters
ME/CFS lacks proven disease-modifying treatments, and understanding the role of oxidative stress and inflammation is critical. This study provides preliminary evidence that targeting these pathways with combined antioxidant supplementation may offer symptomatic benefit, offering a potential therapeutic avenue worth further investigation in larger controlled trials.
Observed Findings
Fatigue severity significantly improved after 8 weeks of supplementation (p=0.021)
Global quality of life significantly improved after 8 weeks (p=0.002)
Total antioxidant capacity increased significantly (p<0.0001)
Circulating cytokine levels decreased significantly (p<0.01 for all measured cytokines)
Sleep disturbance showed no significant improvement (p=0.480)
Inferred Conclusions
Combined CoQ10 and selenium supplementation may produce synergistic antioxidant and anti-inflammatory effects in ME/CFS patients.
The biomarker improvements suggest that redox imbalance and inflammation are addressable targets in ME/CFS pathophysiology.
Long-term combined supplementation warrants further investigation in larger, controlled trials.
Remaining Questions
Would results differ in a blinded, placebo-controlled trial with adequate sample size?
What is the optimal duration of supplementation, and do benefits persist long-term or diminish over time?
What This Study Does Not Prove
This study does not prove that CoQ10 plus selenium is an effective treatment for ME/CFS because it lacked a control group and used an open-label design, making it vulnerable to placebo effects. The small sample size (n=27) and short duration (8 weeks) mean results may not generalize to larger populations or long-term use. Correlation between biomarker changes and symptom improvement does not establish causation.
Tags
Symptom:Unrefreshing SleepFatigue
Biomarker:CytokinesBlood Biomarker
Method Flag:PEM Not DefinedNo ControlsSmall SampleExploratory Only